Prediction: Sept. 30 Will Be a Big Day for the Stock Market. Here Are 2 Stocks to Buy Hand Over Fist Before That

Micron's Sept. 30 fiscal Q4 2026 results and guidance are positioned as a potential catalyst for memory stocks, supported by projected HBM demand growth of 62% in 2027 and 69% in 2028 amid constrained DRAM supply. The article cites analyst forecasts for Micron revenue to rise 90% to $247.5B and EPS to increase 116% to $158.93 in fiscal 2027, although these figures appear unusually large relative to the company's historical scale. Memory-maker capex is projected to rise from $58B last year to $146B in 2027, supporting Lam Research, whose fiscal 2026 revenue grew 26% to $23.2B and whose EPS is expected to rise 63% this fiscal year. Lam trades at 32x forward earnings, and the article estimates potential 142% upside by 2030 if it sustains strong earnings growth and rerates to the Nasdaq's 39x multiple.

Analysis

The useful signal is not the promotional long-term shortage claim but whether MU confirms a durable mix shift toward HBM and high-value server DRAM without sacrificing gross-margin discipline. A favorable print should transmit first to memory-capex equipment—LRCX, AMAT and KLAC—but LRCX has the cleanest operating leverage to wafer-start additions through etch/deposition intensity. The second-order beneficiary is NVDA: incremental qualified HBM supply reduces a binding system-level constraint on accelerator shipments, though memory pricing power can also shift more of the AI profit pool from GPU vendors to DRAM suppliers.

Near term, MU is a crowded event vehicle after a substantial rerating; beat-and-raise is likely required rather than merely strong reported results. The central risk is that suppliers respond to elevated pricing with capacity additions faster than demand materializes, producing the familiar memory-cycle de-rating within 6-18 months; watch capex commitments from Samsung, SK Hynix and CXMT rather than industry shortage forecasts. The article's stated forward revenue/EPS figures are not economically credible for MU and should be disregarded pending consensus-data verification.

Contrarian view: LRCX is not a pure HBM proxy. HBM consumes more process steps, but equipment demand depends on wafer-start expansion and technology-transition intensity, so a tight market resolved through richer pricing and better yields could favor MU while disappointing equipment order expectations. The key 1-3 month catalyst is MU guidance for bit growth, HBM qualification/volume, gross margin and capex; a guide driven by ASPs with restrained capex is positive MU but ambiguous-to-negative for LRCX.

Key Decisions for Investors

• Event trade: buy a defined-risk MU call spread expiring 2-4 weeks after earnings only if implied post-earnings move is below the prior four-quarter average realized move; use a roughly 5% OTM long call / 15% OTM short call structure. Exit on a guide that misses HBM volume or gross-margin expectations, regardless of an EPS beat.
• Initiate a 1-3 month long LRCX / short SOXX pair after MU only if management signals broad 2027 memory-capex acceleration rather than pricing-led growth. Target 8-12% relative upside; cut if MU commentary indicates capex discipline, yield-led supply gains, or customer inventory rebuilding rather than new wafer-fab spending.
• Prefer MU over LRCX for the immediate earnings catalyst if HBM supply remains allocation-constrained; rotate toward LRCX, AMAT and KLAC only after corroboration from Samsung/SK Hynix capex plans and memory-equipment order commentary.
• Set a structural-risk alert for rising DRAM supply guidance, especially from Samsung or CXMT, and for MU inventory days increasing alongside lower bit-growth guidance. Either development would challenge the 6-18 month pricing thesis and warrants reducing cyclical memory exposure.